TransMedics Group, Inc. (NASDAQ:TMDX) Receives $122.70 Average Price Target from Brokerages
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong […]
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong […]
